MRI of the tumor microenvironment

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 4, 2002, Pages 430-450

  Gillies, Robert J ^a   Raghunand, Natarajan ^a   Karczmar, Gregory S ^b   Bhujwalla, Zaver M ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia, diffusion; Perfusion; PH

Indexed keywords

ACID; ANTINEOPLASTIC AGENT; CARBOGEN; CARMUSTINE; CATHEPSIN B; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DEOXYHEMOGLOBIN; DOXORUBICIN; FLUOROURACIL; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 8; MITOMYCIN C; MITOXANTRONE; PACLITAXEL; TAXANE DERIVATIVE; VALSPODAR; VASCULOTROPIN;

ACIDITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; ELECTRON SPIN RESONANCE; HUMAN; HYPOXEMIA; METASTASIS; MICROENVIRONMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN TENSION; PH; PHENOTYPE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; TISSUE PERFUSION; TUMOR VASCULARIZATION;

ANIMALS; CELL HYPOXIA; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS;

EID: 0036793223     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10181     Document Type: Review

References (225)

1. Jain R. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
2. Michael B, Adams G, Hewitt H, et al. A post-effect of oxygen in irradiated bacteria: a submillisecond fast mixing study. Radiat Res 1973;54:239-251.
3. Lemaire L, Howe FA, Rodrigues LM. et al. Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 1999;8:20-26.
4. Alper T, Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli. Nature 1956;178:978-979.
5. Chapman JD, Engelhardt EL, Stobbe CC, et al. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays [Review]. Radiother Oncol 1998;46:229-237.
6. Gulledge CJ, Dewhirst MW. Tumor oxygenation: a matter of supply and demand [Review]. Anticancer Res 1996;16:741-749.
7. Trowell OA. The effect of environmental factors on the radiosensitivity of lymph nodes cultered in vitro. Br J Radiol 1953;306:302-309.
8. Haveman J. The influence of pH on the survival after X-irradition of cultured malignant cells. Effects of carbonylbyanide 3-chlorophenylhydrazone. Int J Radiat Biol 1980;37:201-205.
9. Freeman ML, Sierra E. An acidic extracellular environment reduces the fixation of DNA damage. Radiat Res 1984;97:154-161.
10. Holahan EV, Stuart PK, Dewey WC. Enhancement of survival of CHO cells by acidic pH after X-irradiation. Radiat Res 1982;89: 433-435.
11. Mendonca M, Alpen EL. Extracellular pH and the cell cycle: possible links to radio resistance. In: Proceedings of the 7th International Congress on Radiation Resistance. Amsterdam, The Netherlands, 1983. p b7-b15.
12. Chu GL, Dewey WC. The role of low intracellular or extracellular pH in sensitization to hyperthermia. Radiat Res 1988;114:154-167.
13. Vaupel P. Effect of lactic acid in tumours on antitumour activity of hyperthermia [letter; comment]. Int J Hypertherm 1997;13:247-248.
14. Kitai R, Kabuto M, Kobayashi H, et al. Sensitization to hyperthermia by intracellular acidification of C6 glioma cells. J Neurooncol 1998;39:197-203.
15. Song CW, Lyons JC, Griffin RJ, et al. Increase in thermosensitivity of tumor cells by lowering intracellular pH. Cancer Res 1993;53: 1599-1601.
16. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49:4373-4384.
17. Raghunand N, Mahoney B, van Sluis R, et al. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia (NY) 2001;3:227-235.
18. Phillips RM, Ward TH. Influence of extracellular pH on the cytotoxicity and DNA damage of a series of indolequinone compounds. Anticancer Res 2001;21:1795-1801.
19. Zacher J, Hamilton G, Thalhammer T, et al. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A. and SDZ PSC 833 in dependence on extracellular pH. Cancer Chemother Pharmacol 1994;34:125-132.
20. Rauth AM, Mohindra JK, Tannock IF. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res 1983; 43:4154-4158.
21. Alarcon RM, Denko NC, Giaccia AJ. Genetic determinants that influence hypoxia-induced apoptosis. Novartis Found Symp 2001; 240:115-128.
22. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
23. Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol 2000;76:589-605.
24. Rofstad EK, Danielsen T. Hypoxia indduces metastasis of human melanoma cells: involvement of VEGF mediated angiogenesis. Br J Cancer 2002;80:1697-1707.
25. Young SD, Marshall RS, Hill RP. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 1988;85:9533-9537.
26. Cairns RA, Kalliomaki T, Hill RP, Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 2001; 61:8903-8908.
27. Cuvier C, Jang A, Hill RP. Exposure to hypoxia, glucose starvation and acidosis: effect on the invasive capacity of murine tumor cells and correlation with cathepsin (L+B) secretion. Clin Exp Metast 1997;15:19-25.
28. Parkins CS, Dennis MF, Stratford RL, et al. Ischemia reperfusion injury in tumours: the role of oxygen radicals and nitric oxide. Cancer Res 1995;55:6026-6029.
29. Kimura H, Braun RD, Ong E, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996;56:5522-5528.
30. Jang A, Hill RP. An examination of the effects of hypoxia, acidosis and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metast 1997;15:469-483.
31. Koong AC, Denko NC, Hudson KM, et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883-887.
32. Turner GA. Increased release of tumour cells by collagenase at acidic pH: a possible mechanism for metastasis. Experientia 1979;35:1657-1658.
33. Schlappack OK, Zimmermann A, Hill RP. Glucose starvation and acidosis: effect on experimental metastasic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer 1991; 64:663-670.
34. Bennett DC, Holmes A, Devlin L, et al. Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways. Clin Exp Metast 1994;12:385-397.
35. Martinez-Zaguilan R, Seftor EA, Seftor REB, et al. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metast 1996;14:176-186.
36. Rozhin J, Sameni M, Ziegler G, et al. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 1994;54:6517-6525.
37. Rochefort H, Garcia M, Glondu M, et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview [Review]. Clin Chim Acta 2000;291:157-170.
38. Hill RP, DeJaeger K, Jang A, et al. pH, hypoxia and metastasis. Novartis Found Symp 2001;240:154-165; discussion 165-168.
39. Reshkin SJ, Bellizzi A, Albarani V, et al. Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)/H(+) exchange, motility, and invasion induced by serum deprivation. J Biol Chem 2000;275:5361-5369.
40. Pouyssegur J, Franchi A, Pages G. pH, aerobic glycolysis and VEGF in tumor growth. Novartis Found Symp 2001;240:186-196.
41. Yuan J, Narayanan L, Rockwell S, et al. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 2000;60:4372-4376.
42. Russo CA, Weber TK, Volpe CM, et al. An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. Cancer Res 1995;55:1122-1128.
43. Kondo A, Safaei R, Mishima M, et al. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair. Cancer Res 2001;61:7603-7607.
44. Morita T, Takeda K, Okumura K. Evaluation of clastogenicity of formic acid, acetic acid, and lactic acid on cultured mammalian cells. Mutat Res 1990;240:195-202.
45. Morita T, Nagaki T, Fukuda I, et al. Clastogenicity of low pH to various cultured mammalian cells. Mutat Res 1992;268:297-305.
46. Curthoys NP, Gstraunthaler G. Mechanism of increased renal gene expression during metabolic acidosis [Review]. Am J Physiol-Renal Fluid Electrol Physiol 2001;281:F381-F390.
47. Tang A, Curthoys NP. Identification of zeta-crystallin/NADPH: quinone reductase as a renal glutaminase mRNA pH response element-binding protein. J Biol Chem 2001:276:21375-21380.
48. Curthoys N, Tang A, Gstraunthaler G. pH regulation of renal gene expression. The tumor microenvironment: causes and consequences of hypoxia and acidity. Novartis Found Symp 2001;100-115.
49. Fukumura D, Xu L, Chen Y. et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 2001;61:6020-6024.
50. Scott PA, Gleadle JM, Bicknell R, et al. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer 1998;75:706-712.
51. Shi Q, Le X, Wang B, et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene 2001;20:3751-3756.
52. Stein I, Neeman M, Shweiki D, et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 1995;15:5363-5368.
53. Semenza GL, Agani F, Booth G, et al. Structural and functional analysis of hypoxia-inducible factor 1 [Review]. Kidney Int 1997; 51:553-555.
54. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-472.
55. Wykoff CC, Pugh CW, Maxwell PH, et al. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 2000;19:6297-6305.
56. Clifford SC, Cockman ME, Smallwood AC, et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum Mol Genet 2001;10:1029-1038.
57. Krogh A. The rate of diffusion of gases through animal tissues, with some remarks on the coefficient of invasion. J Physiol 1919;52:391-408.
58. Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 1919;52:409-415.
59. Secomb TW, Hsu R, Braun RD, et al. Analysis of oxygen transport to tumors: causes of heterogeneous tissue oxygenation. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol 1998;454:629-634.
60. Gillies RJ, Schornack PA, Secomb TW, et al. Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1999;1:197-207.
61. Griffiths JR. Causes and consequences of hypoxia and acidity in tumour microenvironments. Bioessays 2001;23:295-296.
62. Nielsen FU, Daugaard P, Bentzen L, et al. Effect of changing tumor oxygenation on glycolytic metabolism in a muring C3h mammary carcinoma assessed by in vivo NMR spectroscopy. Cancer Res 2001;61:5318-5325.
63. Racker E. Why do tumor cells have a high aerobic glycolysis? J Cell Physiol 1976;89:697-700.
64. Racker E, Spector M. Warburg effect revisited: merger of biochemistry and molecular biology. Science 1981;213:303-307.
65. Warburg O. The metabolism of tumours. London: Arnold Constable; 1930.
66. Seagroves T, Ryan HE, Lu H, et al. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol 2001;21:3436-3444.
67. Zhong H, Agani F, Baccala AA, et al. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res 1998;58:5280-5284.
68. Landis CS, Li X, Telang FW, et al. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn Reson Med 1999;42:467-478.
69. Landis CS, Li X, Telang FW, et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000;44:563-574.
70. Bhujwalla ZM, Artemov D, Natarajan K, et al. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 2001;3:143-153.
71. Brindle K. Editorial. NMR Biomed 2002;15:87-88.
72. Maxwell RJ, Wison J, Price VE, et al. Evaluation of the antivascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI. NMR Biomed 2002;15:89-98.
73. Dafni H, Landstrom L, Schechter B, et al. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 2002;15: 120-131.
74. Padhani AR, Hayes CE, Landau S, et al. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 2002;15:143-153.
75. Hawighorst H, Schreiber W, Knopp MV. et al. Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast. Magn Reson Imaging 1996;14:1119-1126.
76. Hawighorst H, Knapstein PG, Knopp MV, et al. Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. MAGMA 1999;8:55-62.
77. Hawighorst H, Schoenberg SO, Knopp MV, et al. Hepatic lesions: morphologic and functional characterization with multiphase breath-hold 3D gadolinium-enhanced MR angiography-initial results. Radiology 1999;210:89-96.
78. Detre JA, Zhang W, Roberts DA, et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 1994;7:75-82.
79. Brown SL, Ewing JR, Kolozsvary A, et al. Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration. Int J Radiat Oncol Biol Phys 1999;43:627-633.
80. Silva AC, Kim SG, Garwood M. Imaging blood flow in brain tumors using arterial spin labeling. Magn Reson Med 2000;44:169-173.
81. Robinson SP, Howe FA, Rodrigues LM, et al. Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. Semin Radiat Oncol 1998;8:197-207.
82. Howe FA, Robinson SP, Rodrigues LM, et al. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn Reson Imaging 1999;17:1307-1318.
83. Dunn TJ, Braun RD, Rhemus WE, et al. The effects of hyperoxic and hypercarbic gases on tumour blood flow. Br J Cancer 1999;80:117-126.
84. Stubbs M, Robinson SP, Rodrigues LM, et al. The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a. Br J Cancer 1998;78:1449-1456.
85. Robinson SP, Rodrigues LM, Howe FA, et al. Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases. Magn Reson Imaging 2001;19:161-166.
86. 31P MRS. NMR Biomed 1996;9:208-216.
87. McSheehy PM, Robinson SP, Ojugo AS, et al. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. Cancer Res 1998;58:1185-1194.
88. Robinson SP, Rodrigues LM, Griffiths JR, et al. Response of hepatoma 9618a and normal liver to host carbogen and carbon monoxide breathing. Neoplasia 1999;1:537-543.
89. Neeman M, Dafni H, Bukhari O, et al. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med 2001;45:887-898.
90. Robinson SP, Collingridge DR, Howe FA, et al. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12:98-106.
91. Howe FA, Robinson SP, McIntyre DJ, et al. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed 2001;14:497-506.
92. Abramovitch R, Dafni H, Smouhas E, et al. In vivo prediction of vascular susceptibiltiy to vascular endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Res 1999;59:5012-5016.
93. Griffiths JR, McIntyre DJ, Howe FA, et al. Issues of normal tissue toxicity in patient and animal studies-effect of carbogen breathing in rats after 5-fluorouracil treatment. Acta Oncol 2001;40: 69-614.
94. Griffiths JR, Taylor NJ, Howe FA, et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;39:697-701.
95. Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging 2001;14:156-163.
96. Al Hallaq HA, Fan X, Zamora M, et al. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed 2002;15:28-36.
97. Posse S, Wiese S, Gembris D, et al. Enhancement of BOLD-contrast sensitivity by single-shot multi-echo functional MR imaging. Magn Reson Med 1999;42:87-97.
98. Parhami P, Fung BM, Fluorine-19 relaxation study of perfluoro chemicals as oxygen carriers. J Physiol Chem 1983;87:1928-1931.
99. Lutz J, Stark M. Half life and changes in the composition of a perfluorocarbon emulsion within the vascular system of rats. Pflugers Arch 1987;410:181-184.
100. 19F magnetic resonance imaging of the reticuloendothelial system [erratum appears in Magn Reson Med 1988;8:117]. Magn Reson Med 1987:5:548-554.
101. 19F magnetic resonance imaging. Invest Radiol 1988; 23:361-364.
102. 19F MRI study in tumor-bearing mice. Magn Reson Imaging 1989;7:475-485.
103. Mason RP, Antich PP, Babcock EE, et al. Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol Biol Phys 1994;29:95-103.
104. Riess JG. Reassessment of criteria for the selection of perfluoro-chemicals for second-generation blood substitutes: analysis of structure/property relationships. Artif Organs 1984;8:44-56.
105. 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 1994;32:88-97.
106. 19F NMR indicator of tumor oxygenation. NMR Biomed 1996;9:125-134.
107. 19F magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 1989;16:925-929.
108. Aboagye EO, Maxwell RJ, Kelson AB, et al. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl] acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. Cancer Res 1997;57:3314-3318.
109. Aboagye EO, Maxwell RJ, Horsman MR, et al. The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554. Br J Cancer 1998;77:65-70.
110. Hockel M, Schlenger K, Knoop C, et al. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res 1991;51:6098-6102.
111. Wong RK, Fyles A, Milosevic M, et al. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. Int J Radiat Oncol Biol Phys 1997;39:405-412.
112. Swartz HM, Clarkson RB. The measurement of oxygen in vivo using EPR techniques. Phys Med Biol 1998;43:1957-1975.
113. Urtasun RC, Parliament MB, McEwan AJ, et al. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside. Br J Cancer Suppl 1996;27:S209-S212.
114. Shi CQ, Sinusas AJ, Dione DP, et al. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia. J Nucl Med 1995;36:1078-1086.
115. Rasey JS, Casciari JJ, Hofstrand PD, et al. Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole. Radiat Res 2000;153:84-92.
116. Martin GV, Cerqueira MD, Caldwell JH, et al. Fluoromisonidazole. A metabolic marker of myocyte hypoxia. Circ Res 1990;67:240-244.
117. Berry JJ, Schwaiger M. Metabolic imaging with positron-emission tomography. Curr Opin Cardiol 1990;5:803-812.
118. Chapman JD. The detection and measurement of hypoxic cells in solid tumors. Cancer 1984;54:2441-2449.
119. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001;7:345-350.
120. Shibata T, Giaccia AJ, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 2000;7:493-498.
121. Raman VR, Artemov D, Mironchik Y, et al. Combined and co-registered MRI, MRSI and optical imaging characterization of tumor vasculariation, metabolism and hypoxia. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, 2002;10:487.
122. Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 1984;2:343-366.
123. Volk T, Jahde E, Fortmeyer HP, et al. pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 1993;68:492-500.
124. Waddell WJ, Butler TC. Calculation of intracellular pH from the distribution of 5,5- dimethyl-2,4-oxazolidinedione (DMO). Application to skeletal muscle of the dog. J Clin Invest 1959;38:720-729.
125. Evelhoch JL, Sapareto SA, Jick DE, et al. In vivo metabolic effects of hyperglycemia in murine radiation-induced fibrosarcoma: a 31P NMR investigation. Proc Natl Acad Sci U S A 1984;81:6496-6500.
126. Evanochko WT, Ng TC, Lilly MD, et al. In vivo 31-P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia. Proc Natl Acad Sci U S A 1983;80:334-338.
127. Melner MH, Sawyer ST, Evanochko WT, et al. Phosphorus-31 nuclear magnetic resonance analysis of epidermal growth factor action in A-431 human epidermoid carcinoma cells and SV-40 virus transformed mouse fibroblasts. Biochemistry 1983;22:2039-2042.
128. Koutcher JA, Damadian R. Spectral differences in the 31P NMR of normal and malignant tissue. Physiol Chem Phys 1977:9:181-187.
129. Thomlinson RH, Gray LH. The histological structure of human lung cancers and the possible implications for radiotherapy. British J of Cancer 1995;9:539-549.
130. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324.
131. Negendank WG, Brown TR, Evelhoch JL, et al. Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology. Radiology 1992;185:875-883.
132. Griffiths JR. Are cancer cells acidic? Br J Cancer 1991;64:425-427.
133. Gillies RJ, Liu Z, Bhujwalla Z. 31P-MRS measurements of extra-cellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 1994;267:c195-c203.
134. Raghunand N, Altbach MI, van Sluis R. et al. Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem Pharmacol 1999;57:309-312.
135. Bhujwalla ZM, Aboagye EO, Gillies RJ, et al. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Magn Reson Med 1999;41:897-903.
136. Bhujwalla ZM, McCoy CL, Glickson JD, et al. Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer 1998;78:606-611.
137. Maxwell RJ, McCoy CL, Griffiths JR. Assessment of double volume acquisition (DIVA) method to minimise chemical shift artifacts in localised 31P MRS. In: Proceedings of the 3rd Annual Meeting of ISMRM, Nice, France, 1995;3:1337.
138. McCoy CL, Parkins CS, Chaplin DJ, et al. The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours. Br J Cancer 1995;72:905-911.
139. 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume. Bioorg Med Chem Lett 1994;2:305-314.
140. 1H NMR probes for intracellular pH. Bioorgan Med Chem Lett 1992;2:1717-1722.
141. 1H MRSI. Magn Reson Med 1999;41:743-750.
142. Bhujwalla ZM, Artemov D, Ballesteros P, et al. Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed 2002:15:114-119.
143. 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res 2001;61:6524-6531.
144. Vermathen P, Capizzano AA, Maudsley AA. Administration and {1}H MRS detection of histidine in human brain: application to in vivo pH measurement. Magn Reson Med 2000;43:665-675.
145. Deutsch C, Erecinska M, Werrlein R, et al. Cellular energy metabolism, trans-plasma and trans-mitochondrial membrane potentials, and pH gradients in mouse neuroblastoma. Proc Natl Acad Sci U S A 1979:76:2175-2179.
146. Taylor JS, Deutsch C. Fluorinated-methylamino acids as 19-F NMR indicators of intracellular pH. Biophys J 1983;43:261-267.
147. Mason RP. Transmembrane pH gradients in vivo: measurements using fluorinated vitamin B6 derivatives. Curr Med Chem 1999;6:481-499.
148. Hunjan S, Mason RP, Mehta VD, et al. Tumor transmembrane pH gradient measurement with 6-fluorophyridoxol by 19F NMR spectroscopy. Magn Reson Med 1998;39:551-556.
149. Ojugo AS, McSheehy PM, McIntyre DJ, et al. Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous {19}F and {31}P probes. NMR Biomed 1999;12:495-504.
150. Aoki Y, Akagi K, Tanaka Y, et al. Measurement of intratumor pH by pH indicator used in 19F-magnetic resonance spectroscopy. Measurement of extracellular pH decrease caused by hyperthermia combined with hydralazine. Invest Radiol 1996;31:680-689.
151. Mikawa M, Miwa N, Brautigam M, et al. Gd{3+}-loaded polyion complex for pH depiction with magnetic resonance imaging. J Biomed Mater Res 2000;49:390-395.
152. Zhang S, Wu K, Sherry AD. A novel pH-Sensitive MRI contrast agent. Angewandte Chemie Int Ed 1999;38:3192-3194.
153. Beauregard DA, Parker D, Brindle KM. Relaxation-based mapping of tumour pH. In: Proceedings of the 6th Annual Meeting of ISMRM, Sydney, Australia, 1998. p 53.
154. Raghunand N, Howison C, Sherry AD, et al. Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Imaging (in press).
155. Hwang TL, van Zijl PC, Mori S. Accurate quantitation of wateramide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme. J Biomolec NMR 1998;11:221-226.
156. Mori S, Eleff SM, Pilatus U, et al. Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn Reson Med 1998;40:36-42.
157. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000;44:799-802.
158. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79-87.
159. Aime S, Barge A, Castelli DD, et al. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002;47:639-648.
160. Zhang S, Winter P, Wu K, et al. A novel europium(III)-based MRI contrast agent. J Am Chem Soc 2001;123:1517-1518.
161. Zhang S, Sherry AD. Paramagnetic CEST agents: a comparison of NH vs OH exchange. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu. 2002;10:2590.
162. Latour LL, Svoboda K, Mitra PP, et al. Time-dependent diffusion of water in a biological model system. Proc Natl Acad Sci U S A 1994;91:1229-1233.
163. Helmer KG, Dardzinski BJ, Sotak CH. The application of porous-media theory to the investigation of time-dependent diffusion in in vivo systems. NMR Biomed 1995;8:297-306.
164. Chen S, Ikawa F, Kurisu K, et al. Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging. AJNR Am J Neuroradiol 2001;22:1089-1096.
165. Chan JH, Tsui EY, Luk SH, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 2001;26:161-165.
166. Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081-1088.
167. Bortner CD, Cidlowski JA. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 1998;56:1549-1559.
168. Smouha E, Neeman M. Compartmentation of intracellular water in multicellular tumor spheroids: diffusion and relaxation NMR. Magn Reson Med 2001;46:68-77.
169. Filippi CG, Edgar MA, Ulug AM, et al. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001;22:65-72.
170. Wu JC, Wong EC, Arrindell EL, et al. In vivo determination of the anisotropic diffusion of water and the T1 and T2 times in the rabbit lens by high-resolution magnetic resonance imaging. Invest Ophthalmol Vis Sci 1993;34:2151-2158.
171. Clark CA, Hedehus M, Moseley ME. Diffusion time dependence of the apparent diffusion tensor in healthy human brain and white matter disease. Magn Reson Med 2001;45:1126-1129.
172. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177:449-454.
173. Glover GH. Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1991;1:521-530.
174. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
175. Doyle M, Mansfield P. Chemical-shift imaging: a hybrid approach. Magn Reson Med 1987;5:255-261.
176. Mansfield P. Spatial mapping of the chemical shift in NMR. Magn Reson Med 1984;1:370-386.
177. Kovar DA, Al Hallaq HA, Zamora MA, et al. Fast spectroscopic imaging of water and fat resonances to improve the quality of MR images. Acad Radiol 1998;5:269-275.
178. Sarkar S, Heberlein K, Metzger GJ, et al. Applications of high-resolution echoplanar spectroscopic imaging for structural imaging. J Magn Reson Imaging 1999;10:1-7.
179. Karczmar GS, Fan X, Al Hallaq HA, et al. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med 2000;43:633-639.
180. Al Hallaq HA, Zamora M, Fish BL, et al. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int J Radiat Oncol Biol Phys 2000;47:481-488.
181. Du W. High spectral and spatial resolution MR imaging of breast-preliminary experience. Radiology (in press).
182. Fan X, River JN, Zamora M, et al. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med 2001;45:1046-1055.
183. Zhong K, Li X, Shachar-Hill Y, et al. Magnetic susceptibility shift selected imaging (MESSI) and localized (1)H{2}O spectroscopy in living plant tissues. NMR Biomed 2000;13:392-397.
184. Xu Y, Balschi JA, Springer Jr CS. Magnetic susceptibility shift selected imaging: MESSI. Magn Reson Med 1990;16:80-90.
185. Dunn JF, Wadghiri YZ, Meyerand ME. Regional heterogeneity in the brain's response to hypoxia measured using BOLD MR imaging. Magn Reson Med 1999;41:850-854.
186. Barth M, Reichenbach JR, Venkatesan R, et al. High -resolution, multiple gradient-echo functional MRI at 1.5 T. Magn Reson Imaging 1999;17:321-329.
187. Rommel E, Kimmich R, T1(rho) dispersion imaging and volume-selective T1(rho) dispersion weighted NMR spectroscopy. Magn Reson Med 1989;12:390-399.
188. Makela H, Groehn O, Kauppinen RA. Effects of pH and ionic environment on the on-resonance T1(rho) in native and cross-linked protein solutions as determined with spin-lock methods. In: Proceedings of the 8th Annual Meeting of ISMRM. Denver, 2000. p 513.
189. Kettunen MI, Groehn O, Penttonen M, et al. Cerebral T1(rho) relaxation time increases immediately upon global ischemia in the rat independently of blood glucose and anoxic depolarization. Magn Reson Med 2001;46:565-572.
190. Hakumaki JM, Groehn O, Tyynela K, et al. Early gene therapy induced apoptotic response in BT4C gliomas by MR relaxation contrast T1 in the rotating frame. Cancer Gene Ther 2002;9:338-345.
191. Goldmann E. The growth of malignant disease in man and the lower animals, with special reference to the vascular system. Proc R Acad Med 1907;1:1-13.
192. Griffiths L, Dachs GU, Bicknell R, et al. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 1997;57:570-572.
193. Shi Q, Abbruzzese JL, Huang S, et al. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 1999;5:3711-3721.
194. Kato Y, Nakayama Y, Umeda M, et al. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 1992;267:11424-11430.
195. Kato Y, Ozono S, Shuin T, et al. Slow induction of gelatinase B mRNA by acidic culture conditions in mouse metastatic melanoma cells. Cell Biol Int 1996;20:375-377.
196. Schlappack OK, Zimmermann A, Hill RP. Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. Br J Cancer 1991;64:663-670.
197. Shweiki D, Neeman M, Itin A, et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 1995;92:768-772.
198. Xu L, Xie K, Mukaida N, et al. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res 1999;59:5822-5829.
199. Graham CH, Forsdike J, Fitzgerald CJ, et al. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999;80:617-623.
200. Ginis I, Faller DV. Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). Cancer Lett 2000;154:163-174.
201. Hasan NM, Adams GE, Joiner MC, et al. Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. Br J Cancer 1998;77:1799-1805.
202. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-943.
203. Stackpole CW, Groszek L, Kalbag SS. Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia. J Natl Cancer Inst 1994;86:361-367.
204. Rofstad EK, Danielsen T. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Br J Cancer 1999;80:1697-1707.
205. Schwickert G, Walenta S, Sundfor K, et al. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995;55:4757-4759.
206. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000;60:916-921.
207. Fratelli M, Galli G, Minto M, et al. Role of clusterin in cell adhesion during early phases of programmed cell death in P19 embryonic carcinoma cells. Biochim Biophys Acta 1996;1311:71-76.
208. Semenza GLA. 'The metabolism of tumours': 70 years later. Novartis Found Symp 2001;240:251-260; discussion 260-264.
209. 31P-MRS measurements of extra-cellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 1994;267:C195-C203.
210. Raghunand N, He X, van Sluis R, et al. Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer 1999;80: 1005-1011.
211. Raghunand N, Altbach MI, van Sluis R, et al. Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy, Biochem Pharmacol 1999;57:309-312.
212. Ojugo AS, McSheehy PM, McIntyre DJO, et al. Measurement of the extracellular pH of solid tumors in mice by magnetic resonance spectroscopy: a comparison of exogenous 19FG and 31P probes. NRM in Biomedicine 1999;12(8):495-504.
213. Stubbs M, Veech RL, Griffiths JR. Tumor metabolism: the lessons of magnetic resonance spectroscopy. Adv Enzyme Regul 1995;35:101-115.
214. Robinson SP, Rodrigues LM, Griffiths JR, et al. Response of hepatoma 9618a and normal liver to respiratory challenge with carbogen or carbon monoxide: an interleaved GRE MRI and 31P MRS study. Neoplasia 1999;1:537-543.
215. Zhao M, Pipe JG, Bonnett J, et al. Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 1996;73:61-64.
216. Ross BD, Chenevert TL, Kim B, et al. Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Q Magn Reson Biol Med 1994;1:89-106.
217. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466.
218. Galons JP, Altbach MI, Paine-Murrieta GD, et al. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999;1:113-117.
219. Poptani H, Puumalainen AM, Grohn OH, et al. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther 1998;5:101-109.
220. Hakumaki JM, Poptani H, Puumalainen AM, et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998;58:3791-3799.
221. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Intervent Radiol 2000;11:1245-1255.
222. Stegman LD, Rehemtulla A, Hamstra DA, et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 2000;7:1005-1010.
223. Jennings D, Hatton BN, Guo J, et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 2002;4:255-260.
224. Mardor Y, Roth Y, Lidar Z, et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 2001;61:4971-4973.
225. Chenevert TL, Stegman LD, Taylor JMG, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic effiacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.